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Abstract.
BACKGROUND: Cardiac surgery with cardiopulmonary bypass is associated with important changes in the micro-
circulation, usually attributed to endothelial dysfunction. Another common finding of cardiac surgery is postoperative
thrombocytopenia and platelet loss of function.
OBJECTIVE: To investigate the association between microvascular flow pattern and postoperative changes in platelet count
and function in cardiac surgery patients.
METHODS: Twelve adult cardiac surgery patients received microvascular circulation (sidestream darkfield sublingual
mucosa analysis) and platelet count and function (multiple electrode aggregometry ADPtest and TRAPtest) assessment
before and after cardiopulmonary bypass.
RESULTS: After cardiopulmonary bypass, sublingual microcirculation showed a significantly (P = 0.001) decreased
microvascular flow index and increased heterogeneity index (P = 0.006). Platelet function significantly decrease after car-
diopulmonary bypass both at ADPtest (P = 0.011) and TRAPtest (P = 0.002). Preoperative patterns of poor microvascular
perfusion (low perfused vessels density and total vessels density) were significantly associated with lower values of post-
cardiopulmonary bypass platelet function (ADPtest, P = 0.009, TRAPtest, P = 0.031) and count (P = 0.048).
CONCLUSIONS: A preoperative disturbance of the microcirculation is associated with a greater postoperative platelet
dysfunction. Endothelial damage, chemical and mechanical stimuli are the possible link between the two patterns.
Keywords: Cardiac surgery, sublingual microcirculation, platelet function, multiple electrode aggegometry
1. Introduction
Patients at increased cardiovascular risk show endothelial glycocalyx and microvascular perturba-
tions [1–3]. This condition has been advocated as a determinant of microvascular angina [4]. Patients
with coronary disease have activated circulating platelets, a decreased platelet reactivity and an ele-
vated platelet adhesion [5, 6]. When myocardial ischemia is determined by multiple coronary lesions,
coronary artery bypass graft (CABG) surgery is still the gold standard. Coronary surgery, with or
without cardiopulmonary bypass (CPB) is accompanied by well-known microcirculatory alterations
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due to a number of mechanisms, including hemodilution, non-pulsatile flow, release of inflammatory
cytokines, platelet activation, and others [7–9].
Coronary surgery with CPB has an important impact on platelet count and function: due to the
extensive release of tissue factor, platelets are activated and post-CPB platelet dysfunction is a common
pattern [10, 11]. Additionally, platelet adhesion to the foreign surfaces of CPB circuit and oxygenator,
as well as to the activated endothelial surface, together with blood loss concur in the determination of
variable patterns of thrombocytopenia. Platelet adhesion is accompanied by activation, release reaction
and spreading [12]. This also leads to an activation of the circulating platelets.
Platelet activation is a complex phenomenon involving chemical and mechanical factors. Among
the latter, shear-stress plays an important role as a platelet activator, and impaired microcirculatory
conditions may create the substrate for platelet adhesion, activation, and loss of count and function.
Therefore, coronary surgery with CPB represents an interesting setting where pre-operative endothe-
lial dysfunction, intraoperative microvascular impairment, and platelet activation are simultaneously
present and may concur in determining post-operative organ dysfunction [13–16].
The present study investigates the changes in platelet count and function in the setting of coronary
surgery with CPB, and in relation to the pre and post-CPB conditions of the microcirculation.
2. Material and methods
Prospective cohort study conducted at the cardiac anesthesia and intensive care department of the
IRCCS Policlinico San Donato between October 2017 and January 2018. Data from this study were
obtained by two ongoing prospective cohort studies registered at clinicaltrials.gov with identifier codes
NCT03169608 (microcirculation) and NCT03121898 (platelet function). The studies were approved
by the local Ethics Committee of the IRCCS San Raffaele Hospital, and all the patients provided a
written informed consent.
2.1. Patients
The study included twelve adult patients receiving CABG surgery (with or without additional pro-
cedures) at our institution. All the patients were operated under elective conditions and were free from
the effects of anti-platelet agents acting on the P2Y12 receptor. Aspirin treatment was not discontinued.
2.2. Surgery, anesthesia, and CPB
According to our standard practice, the patients received a premedication with intramuscular atropine
(0.5 mg) and fentanyl (100g) about 1 hour before reaching the operating theater. Anesthesia was
induced with an intravenous bolus injection of propofol at 1.5 mg·kg–1 and infusion of remifentanil
0.2g·kg–1·min–1· Maintenance of anesthesia was achieved with a continuous infusion of propofol at
3 mg·kg–1·h–1 and a remifentanil infusion range from 0.05 to 0.5g·kg–1·min–1· Additional inhalatory
agents (sevorane) could be used as requested.
CPB was conducted using open circuits, phosphorylcholine coated hollow-fiber oxygenators, and
centrifugal pumps. Regardless of the circuit used, the priming volume was always minimized to
600–800 mL. The lowest temperature on CPB was decided by the surgeon, but was kept within a range
of 32 ◦C – 34 ◦C. The CPB flow was adjusted in order to maintain a mean perfusion pressure in the range
of 60–80 mmHg and adequate oxygen delivery. If needed, systemic vasoconstrictor (norepinephrine)
or vasodilator (sodium nitroprusside) infusions were used in order to keep the perfusion pressure within
the range. Cold crystalloid or blood cardioplegia were used according to the surgeon’s preference.
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2.3. Data collection and deﬁnitions
The following perioperative data were collected: demographics; family history of coronary disease;
dyslipidemia; hypertension; serum creatinine levels (mg/dL); hematocrit (%) before CPB, nadir value
on CPB, and after weaning from CPB; platelet count (x1,000 cells/L) before CPB and at the end of
the procedure; diabetes (on medication); ongoing use of beta-blockers, angiotensin converting enzyme
inhibitors, diuretics, calcium antagonists, aspirin; CPB duration (minutes); fluid administration before
CPB; priming volume (mL); type of surgery; transfusions of red blood cells; use of inotropic/vasoactive
drugs (dopamine, epinephrine, nor-epinephrine) for CPB weaning.
At two points in time (after induction of anesthesia before surgical incision, and after weaning from
CPB) platelet function and microcirculation status were assessed as subsequently explained.
2.4. Platelet function assessment
ADP-dependent and thrombin-dependent platelet aggregability were assessed using a multiple-
electrode aggregometry (MEA, Multiplate, Roche Diagnostics, Indianapolis, IN).
An amount of 3 mL of blood was drawn from a venous line and collected in hirudin-coated tubes
provided by the manufacturer. Platelet function tests were performed within 30 minutes from the arrival
in our point-of-care coagulation laboratory, that is situated in the operating room, and after 30 minutes
from blood collection.
Platelet aggregation testing on the MEA analyzer was performed as follows. Briefly, 300L of
whole blood were added to an equal amount of preheated saline solution and platelet aggregation was
tested after specific activation with adenosine diphosphate (ADP, ADPtest, 6.5M final concentration)
and thrombin-activating peptide (TRAP-6, TRAPtest, 32M final concentration). P2Y12 receptors are
inhibited by direct ADP receptor inhibitors (clopidogrel, ticlopidine, prasugrel and ticagrelor), whereas
TRAP test is sensitive to GPIIbIIIa inhibitors and, being a potent platelet activator via thrombin
receptors, in the absence of specific inhibiting drugs, represents the “natural” maximum aggregation
potential of the platelets. Platelet aggregation was electronically measured for 6 minutes and expressed
as units of area under the curve plotted over time (AUC, [U]).
Normal reference range for ADPtest is 57–113 (U) and for TRAPtest is 84–128 (U).
Platelet reactivity at MEA is routinely performed in two parallel channels, to check for intra-test
variability. The test was planned to be repeated if the results differed more than the reference range
provided by the manufacturer.
2.5. Microcirculation assessment
A proper evaluation of microcirculatory status should include an assessment of vascular density,
capillary perfusion and the heterogeneity of perfusion.
For such purpose a number of microcirculatory parameters have been employed in clinical practice.
Briefly, the De Backer score approximates vessel density using a line-crossing method. Total vessel
density (TVD, mm/mm2) is another measure of vessel density, while perfused vessel density (PVD
mm/mm2) and proportion of perfused vessels (PPV,%) correspond to the density of functionally flowing
capillaries. PPV refers to the percentage of perfused vessels with respect to the total vessels in each
sequence.
The microvascular flow index (MFI) is a semi-quantitative measure of capillary perfusion quality.
Perfused vessels are those with a constant or sluggish flow, and non–perfused vessels are those with
intermittent or absent flow.
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Finally, the Heterogeneity Index (HI) evaluates the heterogeneity or variability of predominant blood
flow between sequences at a single time point at different sites of detection.
The sublingual microcirculation was evaluated at four different sites using sidestream dark field
(SDF) videomicroscopy (Microscan, Microvision Medical, Amsterdam, NL). Four images per time-
point were analyzed using the Automated Vascular Analysis (AVA) software version 4.1 (Microvision
Medical BV). TVD, PVD, De Backer score [17], PPV,MFI, and HI were calculated. The SDF was
extensively described elsewhere [18, 19]. Briefly, in SDF imaging, illumination is provided by sur-
rounding a central light guide by concentrically placed light emitting diodes (LEDs). The lens system
in the core of the light guide is optically isolated from the illuminating outer ring. Light from the SDF
probe penetrates the tissue and illuminates the tissue-embedded microcirculation by scattering. The
LEDs emit at a central green wavelength to ensure optimal optical absorption by the hemoglobin in
the RBCs, independent of its oxygenation state. In the final image, RBCs are imaged as dark moving
globules against a white/grayish background. To improve the imaging of flowing RBCs, the LEDs
provide pulsed illumination [18, 19].
The saliva was gently removed with gauzes and the SDF probe was then positioned under the tongue.
Thereafter, four consecutive videos were recorded at different areas of the sublingual mucosa.
The SDF images were recorded at two points in time: after the induction of anesthesia and before
CPB; and after weaning from CPB.
The values of PPV, TVD, PVD, and De Backer score were automatically produced by the AVA 4.1
software. Conversely, MFI and HI were calculated off-line by visual analysis. Perfusion was categorized
by eye as absent (0), intermittent (1), sluggish (2), or normal (3) and then we calculated the average
values of the four quadrants. Finally, the heterogeneity index (HI) was calculated taking into account
the highest site flow velocity minus the lowest site flow velocity, divided by the mean flow velocity of
all sublingual sites [20].
2.6. Statistics
Continuous variables are presented as median with interquartile range in text, and tables and as
median, interquartile range, and 95% confidence interval in figures. Binary variables are presented as
number and percentage.
Differences between the continuous variables measured before and after CPB were tested with
non-parametric tests for related samples (Wilcoxon test).
Associations between continuous variables were tested using Pearson’s correlation matrixes produc-
ing correlation coefficients (R) and P values. All tests were two-sided; a P value < 0.05 was considered
statistically significant.
The association between continuous variables being significant at the correlation matrix were sub-
sequently explored using linear and non-linear regression analyses, producing the best-fit relationship
with 95% confidence interval, squared correlation coefficient (R2) and P values for association.
All the analyses were performed using computerized statistical packages (SPPS 13.0, IBM, Chicago,
IL, and GraphPad Prism 7.0, GraphPad Software, Inc., La Jolla, CA).
3. Results
Table 1 reports the general characteristics of the patient population. Microcirculation parameters
before and after CPB are reported in Fig. 1. After CPB there was a significant (P = 0.001) decrease
of the MFI and a significant (P = 0.006) increase of the HI. The De Backer score (not in Fig. 1) did
not significantly change (P = 0.943) from before (median 11.8, interquartile range 11.1–12.6) to after
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Table 1
General characteristics of the patient population (N = 12)
Factor Value
Age (years) 69.5 (64.2–79.2)
Weight (kgs) 69 (65–74.5)
Height (cms) 167 (160–169.5)
Gender male/female 10 (82.3)/2(17.7)
History of coronary disease 1 (8.3)
Serum creatinine (mg/dL) 0.87 (0.80–1.08)
Hypertension 8 (66)
Diabetes on medication 5 (41.7)
Dyslipidemia 6 (50)
Ongoing drugs
Beta-blockers 6 (50)
ACE-inhibitors 5 (41.7)
Calcium antagonists 1 (8.3)
Diuretics 7 (58.3)
Aspirin 4 (33.3)
Hematocrit (%)
Baseline 39 (36.3–40.7)
Nadir on CPB 27 (24.2–30)
After weaning from CPB 28.5 (26.5–32)
Platelet count (x1,000 cells/L)
Baseline 224 (182–246)
End procedure 147 (111–178)
Surgery
Isolated CABG 6 (50)
CABG+valve procedure 6 (50)
CPB duration (min) 80 (57–106)
Nadir temperature on CPB (◦C) 31.8 (31.3–32.5)
Fluids before CPB (mL) 850 (800–1125)
Priming volume (mL) 700 (700–800)
Red blood cells transfusions 2 (16.7)
Inotropic drugs at CPB weaning 5 (41.7)
ACE: angiotensin converting enzyme; CABG: coronary artery bypass graft; CPB:
cardiopulmonary bypass. Data are number (%) or median (interquartile range).
CPB (median 11.3, interquartile range 11.2–11.8). Platelet count and function parameters are reported
in Fig. 2. After CPB, platelet count significantly decreased, as well as platelet function at both the
ADPtest and the TRAPtest.
The association between microcirculation parameters and platelet-related parameters were investi-
gated with a correlation matrix, reported in Table 2.
No significant association was found between post-CPB microcirculation parameters and any param-
eter related to platelet count or function. Pre- CPB PPV, MFI and HI did not show any significant
association with any parameter related to platelet count and function.
There were significant associations between pre-CPB PVD, TVD, De Backer score and parameters
of platelet count/function. In details, higher values of pre-CPB PVD were associated with a greater post-
CPB platelet count (P = 0.048), a higher post-CPB ADPtest (P = 0.009) and TRAPtest (P = 0.031), and
a lower decrease of platelet count from pre to post-CPB (P = 0.017). Similar results were mirrored by
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Fig. 1. Microcirculation parameters before (pre) and after (post) cardiopulmonary bypass. HI: heterogeneity index; MFI:
microvascular flow index; PPV: proportion of perfused vessels; PVD: perfused vessels density; TVD: total vessels density.
Boxes are interquartile range, lines in the box are median, whiskers are 95% confidence interval.
Fig. 2. Platelet count and function before (pre) and after (post) cardiopulmonary bypass. MEA: multiple electrode aggre-
gometry. Boxes are interquartile range, lines in the box are median, whiskers are 95% confidence interval.
the pre-CPB TVD, with a higher post-CPB ADPtest (P = 0.021) and lower decreases (from pre to post-
CPB) of platelet count (P = 0.043) and function at the ADPtest (P = 0.006) and TRAPtest (P = 0.039).
Finally, a higher De Backer score was associated with a higher post-CPB ADPtest (P = 0.014).
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Table 2
Association between microcirculation parameters and platelet function tests (N = 12)
Parameter PPVpre PVDpre TVDpre De Backer MFIpre Hipre PPVpost PVDpost TVDpost De Backer MFIpost Hipost
(%) (n/mm2) (n/mm2) pre (%) (%) (n/mm2) (n/mm2) post (%)
PLTcount preCPB R = 0.137 R = 0.006 R = –0.075 R = –0.056 R = –0.355 R = –0.384 R = 0.077 R = 0.152 R = 0.138 R = 0.277 R = –0.177 R = –0.094
(cells/L) P = 0.601 P = 0.981 P = 0.776 P = 0.832 P = 0.161 P = 0.128 P = 0.769 P = 0.561 P = 0.597 P = 0.281 P = 0.497 P = 0.721
ADPtest R = 0.566 R = 0.034 R = –0.259 R = 0.320 R = –0.253 R = 0.443 R = 0.195 R = 0.112 R = 0.005 R = 0.130 R = –0.040 R = 0.225
preCPB (U) P = 0.055 P = 0.916 P = 0.416 P = 0.310 P = 0.408 P = 0.139 P = 0.744 P = 0.730 P = 0.987 P = 0.688 P = 0.903 P = 0.482
TRAPtest R = 0.508 R = 0.037 R = –0.239 R = 0.276 R = –0.034 R = 0.149 R = 0.095 R = 0.230 R = 0.187 R = 0.413 R = 0.114 R = 0.126
preCPB (U) P = 0.092 P = 0.908 P = 0.404 P = 0.385 P = 0.916 P = 0.644 P = 0.768 P = 0.473 P = 0.561 P = 0.182 P = 0.724 P = 0.695
PLTcount postCPB R = 0.188 R = 0.485 R = 0.357 R = 0.248 R = 0.128 R = –0.169 R = –0.255 R = 0.293 R = –0.244 R = –0.134 R = 0.118 R = –0.210
(cells/L) P = 0.469 P = 0.048* P = 0.159 P = 0.336 P = 0.625 P = 0.518 P = 0.733 P = 0.254 P = 0.344 P = 0.609 P = 0.651 P = 0.409
ADPtest R = 0.123 R = 0.707 R = 0.653 R = 0.687 R = –0.006 R = 0.138 R = –0.375 R = –0.183 R = –0.056 R = –0.258 R = 0.346 R = –0.395
postCPB (U) P = 0.702 P = 0.009** P = 0.021* P = 0.014* P = 0.985 P = 0.669 P = 0.229 P = 0.568 P = 0.864 P = 0.418 P = 0.271 P = 0.204
TRAPtest R = 0.211 R = 0.621 R = 0.510 R = 0.543 R = 0.308 R = –0.088 R = –0.442 R = –0.174 R = 0.007 R = –0.122 R = –0.122 R = –0.417
postCPB (U) P = 0.511 P = 0.031* P = 0.090 P = 0.068 P = 0.330 P = 0.786 P = 0.151 P = 0.588 P = 0.983 P = 0.705 P = 0.705 P = 0.177
DeltaPLTcount R = –0.088 R = –0.568 R = –0.496 R = –0.349 R = –0.199 R = –0.179 R = 0.378 R = 0.416 R = –0.425 R = –0.432 R = 0.035 R = 0.155
(cells/L) P = 0.738 P = 0.017* P = 0.043* P = 0.170 P = 0.443 P = 0.491 P = 0.135 P = 0.090 P = 0.089 P = 0.084 P = 0.895 P = 0.552
DeltaADPtest (U) R = 0.318 R = –0.564 R = –0.737 R = –0.335 R = –0.183 R = 0.214 R = 0.458 R = 0.236 R = –0.050 R = 0.311 R = –0.318 R = 0.497
P = 0.314 P = 0.056 P = 0.006** P = 0.287 P = 0.570 P = 0.503 P = 0.134 P = 0.460 P = 0.876 P = 0.324 P = 0.314 P = 0.101
DeltaTRAPtest (U) R = 0.266 R = –0.453 R = –0.600 R = –0.190 R = –0.269 R = 0.195 R = 0.425 R = 0.330 R = –0.163 R = 0.445 R = –0.278 R = 0.432
P = 0.404 P = 0.139 P = 0.039* P = 0.554 P = 0.398 P = 0.544 P = 0.168 P = 0.294 P = 0.862 P = 0.147 P = 0.382 P = 0.160
* = P < 0.05; ** = P < 0.01.
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The relationship between pre-CPB PVD and post-CPB ADPtest and TRAPtest are reported in Figs. 3
and 4, respectively. The best fit for the ADPtest is defined by a cubic equation (R2 = 0.600, P = 0.015)
and for the TRAPtest by a linear equation (R2 = 0.386, P = 0.031).
Figure 5 defines the relationship between pre-CPB TVD and the delta pre-post CPB ADPtest. The
best association was found for a linear equation (R2 = 0.544, P = 0.006).
4. Discussion
The main finding of our study is that pre-CPB microcirculatory status determines significant changes
in post-CPB platelet count and especially function. The most relevant associations are found for the
Fig. 3. Cubic regression analysis for association between pre-cardiopulmonary bypass (CPB) perfused vessels density and
post-CPB multiple electrode aggregometry (MEA) ADPtest. Dashed lines delimit the 95% confidence interval (gray zone).
Fig. 4. Linear regression analysis for association between pre-cardiopulmonary bypass (CPB) perfused vessels density and
post-CPB multiple electrode aggregometry (MEA) TRAPtest. Dashed lines delimit the 95% confidence interval (gray zone).
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Fig. 5. Linear regression analysis for association between pre-cardiopulmonary bypass (CPB) total vessels density and pre-
to post-CPB multiple electrode aggregometry (MEA) changes in ADPtest. Dashed lines delimit the 95% confidence interval
(gray zone).
pre-CPB PVD and TVD: for both these measures of the microcirculatory status, higher values
correspond to a better platelet function preservation, especially in terms of platelet reactivity to
ADP-mediated stimulation of the P2Y12 receptor.
This relationship can be interpreted in terms of a protective effect of a well-working microcircu-
lation against the effects of CPB: in fact, pre-CPB TVD has a negative association with the pre-post
CPB difference in platelet count (P = 0.043) and an even stronger association with the pre-post CPB
difference in platelet function at the ADPtest (P = 0.006) and the TRAPtest (P = 0.039).
Cardiac surgery with CPB exerts deleterious effects on the microcirculatory conditions, with a
generalized loss of functional capillary density, and increased flow heterogeneity [7–9]. Additionally,
both platelet count and function show a generalized decrease [11] which is one of the determinants of
postoperative bleeding [21].
Our study confirms these findings, both in terms of microcirculation impairment and platelet loss
of function. Our results link these changes together, opening the window for a number of possible
interpretations.
In previous studies using the SDF technology, cardiac surgery with CPB decreased the functional cap-
illary density [8], as well as the proportion and density of perfused small vessels [7], and these changes
are irrespective of hemodynamic changes [22]. The main mechanisms underlying this microvascu-
lar perfusion impairment are inflammatory and endothelial activation [9]. Endothelial dysfunction
in particular is advocated to play a major role through a glycocalyx alteration [9]. Glycocalyx dis-
ruption is associated with cardiovascular disease, and measures of glycocalyx integrity are possible
with the SDF technology [23]. Damage of the glycocalyx disrupts the natural anti-inflammatory and
anti-coagulant properties of the endothelium, and may create a prothrombotic condition triggered by
platelet adhesion to the endothelial surface and subsequent platelet aggregation. In other clinical con-
ditions where the glycocalyx is disturbed (like sepsis), platelet rolling and adsorption to the endothelial
surface is considered both a determinant and a consequence of the observed microvascular perfusion
alterations [24].
During CPB, platelets are activated by contact with the foreign surfaces, shear stress, inflammation
and coagulation factors. In particular, thrombin is extensively formed on CPB, due to the release
of tissue factor from the surgical wounds [25]. Thrombin is a powerful platelet activator through the
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protease-activated receptors (PAR); the extensive and continuous platelet activation on CPB determines
platelet exhaustion and loss of function. This mechanism is clearly confirmed by our data, with a
significant decrease of platelet function at the ADPtest and the TRAPtest (exploring PAR-reactivity)
after CPB. Additionally other mechanisms may contribute to this pattern. An important determinant
of both platelet adhesion and aggregation processes is the shear stress. At an elevated shear stress both
the von Willebrand Factor (vWF) and the GPIb-IX-V complex change their conformation and increase
their affinity [26]. Additionally, an elevated shear stress triggers platelet aggregation through binding
of the vWF to the GPIb-IX-V complex in the fluid phase [27]. The conformational change of the vWF
leads to a higher accessibility of the vWF-A1 domain which is the most important epitope for bridging
between platelets or surfaces and which is hidden as long the vWF is circulating in a globular shape
[28, 29].
In summary, our interpretation of the link between a pre-CPB altered microcirculation and the loss
of platelet count and function during CPB is that an altered endothelium, together with an increased
shear stress and the release of pro-inflammatory and pro-coagulant factors is the determinant of platelet
activation, adhesion, aggregation, and consequent loss of number and function. Conversely, a well-
working microcirculation is associated with a lower degree of CPB-induced platelet dysfunction,
probably through the maintenance of its anti-inflammatory and anti-coagulant properties.
There are limitations in our study. The main one is the limited patient population. With larger
sample sizes, it could be possible to link the microcirculation and platelet-related changes to clinically
relevant outcomes, like postoperative bleeding and thrombotic events. A second limitation is that
we could not deeply explore the endothelial function with specific techniques like flow-mediated
dilation and/or measure of specific endothelium-derived mediators. Despite this, we believe that our
data may be relevant for understanding the complex pathophysiology of CPB-related changes in both
microcirculation and platelet function.
Acknowledgments
This study was supported by Italian Ministry of Health, grant GR-2013-02356272 to V. Bari and by
an external support by Roche Diagnostics, which provided the Multiplate reagents free of charge.
References
[1] Badimon L, Bugiardini R, Cenko E, Cubedo J, Dorobantu M, Duncker DJ, et al. Position paper of the European Society
of Cardiology-working group of coronary pathophysiology and microcirculation: Obesity and heart disease. Eur Heart J.
2017;38:1951-8.
[2] Martens RJ, Vink H, van Oostenbrugge RJ, Staals J. Sublingual microvascular glycocalyx dimensions in lacunar stroke
patients. Cerebrovasc Dis. 2013;35:451-4.
[3] Mulders TA, Nieuwdorp M, Stroes ES, Vink H, Pinto-Sietsma SJ. Non-invasive assessment of microvascular dysfunction
in families with premature coronary artery disease. Int J Cardiol. 2013;168:5026-8.
[4] Jaarsma C, Vink H, van Haare J, Bekkers SCAM, van Rooijen BD, Backes WH, et al. Non-invasive assessment of
microvascular dysfunction in patients with microvascular angina. Int J Cardiol. 2017;248:433-9.
[5] Braune S, Groß M, Walter M, Zhou S, Dietze S, Rutschow S, et al. Adhesion and activation of platelets from subjects
with coronary artery disease and apparently healthy individuals on biomaterials. J Biomed Mater Res B Appl Biomater.
2016;104:210-7.
[6] Reinthaler M, Braune S, Lendlein A, Landmesser U, Jung F. Platelets and coronary artery disease: Interactions with
the blood vessel wall and cardiovascular devices. Biointerphases. 2016;11:029702.
[7] De Backer D, Dubois M-J, Schmartz D, Koch M, Ducart A, Barvais L, et al. Microcirculatory alterations in cardiac
surgery: Effects of cardiopulmonary bypass and anesthesia. Ann Thorac Surg. 2009;88:1396-403.
Co
rre
cte
d P
roo
f
U. Di Dedda et al. / The combined effects of the microcirculatory status 11
[8] Atasever B, Boer C, Goedhart P, Biervliet J, Seyffert J, Speekenbrink R, et al. Distinct alterations in sublingual micro-
circulatory blood flow and hemoglobin oxygenation in on-pump and off-pump coronary artery bypass graft surgery.
J Cardiothorac Vasc Anesth. 2011;25:784-90.
[9] Konig Nj, Atasever B, Vonk A, Boer C. Changes in microcirculatory perfusion and oxygenation during cardiac surgery
with or without cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2014;28:1331-40.
[10] Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D. Multiple electrode whole-blood aggregometry
and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg. 2011;91:123-9.
[11] Agarwal S, Johnson RI, Kirmani BH. Pre- and post-bypass platelet function testing with multiple electrode aggregometry
and TEG platelet mapping in cardiac surgery. J Cardiothorac Vasc Anesth. 2015;29:1272-6.
[12] Jung F, Braune S. Thrombogenicity and hemocompatibility of biomaterials. Biointerphases. 2015;11:029601.
[13] Olechowski B, Khanna V, Mariathas M, Ashby A, Dalton RT, Nordon I, et al. Changes in platelet function with
inflammation in patients undergoing vascular surgery. Platelets. 2017;11:1-9.
[14] Orvin K, Barac YD, Kornowski R, Perl L, Wasserstrum Y, Rubchevsky V, et al. Monitoring platelet reactivity during
prasugrel or ticagrelor washout before urgent coronary artery bypass grafting. Coron Artery Dis. 2017;28:465-71.
[15] Gruzdeva O, Uchasova E, Fanaskova E, Akbasheva O, Penskaya T, Plotnikov G, et al. Use of thrombin generation test
for monitoring hemostasis in coronary bypass surgery. Clin Hemorheol Microcirc. 2017;66:57-66.
[16] Mazzeffi M, Lund L, Wallace K, Herrera AV, Tanaka K, Odonkor P, et al. Effect of cardiopulmonary bypass on platelet
mitochondrial respiration and correlation with aggregation and bleeding: A pilot study. Perfusion. 2016;31:508-15.
[17] De Backer D, Hollenberg S, Boerma C, Goedhart P, Bu¨chele G, Ospina-Tascon G, et al. How to evaluate the microcir-
culation: Report of a round table conference. Crit Care. 2007;11:R101.
[18] Ince C. Sidestream dark field (SDF) imaging: An improved technique to observe sublingual microcirculation. Crit Care.
2005;8(suppl 1):72.
[19] Goedhart PT, Khalilzada M, Bezemer R, Merza J, Ince C. Sidestream dark field (SDF) imaging: A novel stroboscopic
LED ring-based imaging modality for clinical assessment of the microcirculation. Opt Express. 2007;15:15101-14.
[20] Trzeciak S, Dellinger RP, Parrillo JE, Guglielmi M, Bajaj J, Abate NL. Early microcirculatory perfusion derangements
in patients with severe sepsis and septic shock: Relationship to hemodynamics, oxygen transport, and survival. Ann
Emerg Med. 2007;49:88-98.
[21] Ranucci M. Hemostatic and thrombotic issues in cardiac surgery. Semin Thromb Hemost. 2015;41:84-90.
[22] Den Uil CA, Lagrand WK, Spronk PE, van Domburg RT, Hofland J, Lu¨then C, et al. Impaired sublingual microvascular
perfusion during surgery with cardiopulmonary bypass: A pilot study. J Thorac Cardiovasc Surg. 2008;136:129-34.
[23] Vlahu CA, Lemkes BA, Struijk DG, Koopman MG, Krediet RT, Vink H. Damage of the endothelial glycocalyx in
dialysis patients. J Am Soc Nephrol. 2012;23:1900-8.
[24] De Backer D, Orbegozo Cortes D, Donadello K, Vincent J-L. Pathophysiology of microcirculatory dysfunction and the
pathogenesis of septic shock. Virulence. 2014;5:73-9.
[25] Edmunds LH, Colman RW. Thrombin during cardiopulmonary bypass. Ann Thorac Surg. 2006;82:2315-22.
[26] Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von
Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 1987;69:625-8.
[27] Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996;88:1525-41.
[28] Chen W, Luo J, Zhu C. Molecular dynamics simulated unfolding of von Willebrand Factor A domains by force. Cell
Mol Bioeng. 2009;2:75-86.
[29] Schneider SW, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, Netz RR, et al. Shear-induced unfolding
triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci U S A. 2007;104:7899-903.
